This weekend at the ASH Meeting on Hematological Malignancies (ASHMHM15), Lymphoma Program Director, Dr. John Leonard will discuss how he treats patients with mantle cell lymphoma, and specifically on how to overcome mantle cell lymphoma resistance to ibrutinib.
Category: Lymphoma Program News
New Developments in Lymphoma – Summer 2015 Newsletter
The Lymphoma Program has published the summer 2015 edition of the New Developments in Lymphoma Newsletter.
Please look to this space for further announcements of future newsletter issues, or add your name to our mailing list.
Tweet Chat Recap with Dr. John Leonard on “How I Treat” & the ASH Meeting on Hematologic Malignancies
Yesterday afternoon, Dr. John Leonard answered questions in a Tweet chat hosted by @ASH_hematology on the topics of “How I Treat” and the ASH Meeting on Hematologic Malignancies. This clinical conference will be held in Chicago next month from September 17th to September 19th, and seeks to bring hematological malignancies experts from around the world to discuss the latest developments in clinical care.
Dr. Leonard will present on the treatment of mantle cell lymphoma.
In case you were unable to participate a transcript of the Tweet Chat is available.
New Developments in Lymphoma 